Your account is not claimed yet. You can sign up with ORCID to claim your account.

Kalasekhar Vijayasekharan

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Venues

Leukemia & lymphoma

Cytometry. Part B, Clinical cytometry

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Pediatric hematology and oncology

Kasturba Medical College

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kasturba Medical College Sep 14o 2019

India

Assistant professor :: Division of pediatric hematology oncology

Publications

Harish Varma Tandra, Thirumala Rupakumar, Kalasekhar Vijayasekharan, Prasanth V R, Guruprasad C S, Priya Kumari T
A stitch in time saves nine: timely use of N-acetyl cysteine (NAC) for chemotherapy-induced veno-occlusive disease (VOD)-is it a cost-effective alternative? Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 30 (11) (2022)
Kalasekhar Vijayasekharan, Anand Kc, Maya Prasad, Chetan Dhamne, Nirmalya Roy Moulik, Tanuja Shet, Epari Sridhar, Siddhartha Laskar, Seema Kembhavi, Sneha Shah, Sumeet Gujral, Gaurav Narula, Shripad D Banavali
Clinical outcomes and prognostic factors in children with B-cell lymphoblastic lymphoma (LBL) treated according to on modified BFM-90 protocol: Experience from a Tertiary cancer care center in India. Pediatric hematology and oncology 39 (5) (2022)
Kalasekhar Vijayasekharan, Gaurav Chatterjee, Subramaniam Ramanathan, Gaurav Narula, Prashant Ramesh Tembhare, Papagudi G Subramanian, Nikhil V Patkar, Sumeet Gujral, Dhanalaxmi Shetty, Shripad D Banavali
Sudden blast phase in pediatric chronic myeloid leukemia-chronic phase with abnormal lymphoid blasts detected by flow cytometry at diagnosis: Can it be considered a warning sign? Cytometry. Part B, Clinical cytometry 100 (3) (2020)
Kalasekhar Vijayasekharan, Maya Prasad, Nirmalya D Pradhan, Deepa Phillip, Sumeet Gujral, Tanuja Shet, Epari Sridhar, Seema Kembhavi, Sneha Shah, Shripad D Banavali, Gaurav Narula
Favorable outcomes and reduced toxicity with a novel vinblastine-based non-high dose methotrexate (HDMTX) regimen (modified MCP-842) in pediatric anaplastic large cell lymphoma (ALCL): experience from India. Leukemia & lymphoma 61 (4) (2019)

Kalasekhar Vijayasekharan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kalasekhar Vijayasekharan